BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+21.94%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.74B
AUM Growth
+$2.74B
(+15%)
Cap. Flow
+$297M
Cap. Flow
% of AUM
10.84%
Top 10 Holdings %
Top 10 Hldgs %
49.25%
Holding
82
New
4
Increased
18
Reduced
6
Closed
10
Top Buys
| 1 |
Protagonist Therapeutics
PTGX
|
$86.8M |
| 2 |
Galapagos
GLPG
|
$79.8M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$51.4M |
| 4 |
Structure Therapeutics
GPCR
|
$41.6M |
| 5 |
Revolution Medicines
RVMD
|
$36.8M |
Top Sells
| 1 |
Arcus Biosciences
RCUS
|
$47.6M |
| 2 |
Cullinan Oncology
CGEM
|
$44.1M |
| 3 |
Viridian Therapeutics
VRDN
|
$27.2M |
| 4 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$21.2M |
| 5 |
Annexon
ANNX
|
$19.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
X4 Pharmaceuticals
XFOR
$70M
| – | – |
-1,347,650
| Closed | -$1.34M |
|
77
Cartesian Therapeutics
RNAC
$267M
| – | – |
-1,391,749
| Closed | -$1.57M |
|
|
78
Arcus Biosciences
RCUS
$1.24B
| – | – |
-2,303,520
| Closed | -$47.6M |
|
79
Pyxis Oncology
PYXS
$91.2M
| – | – |
-2,938,851
| Closed | -$3.94M |
|
80
Generation Bio
GBIO
$40.3M
| – | – |
-102,900
| Closed | -$404K |
|
81
Cogent Biosciences
COGT
$1.83B
| – | – |
-984,824
| Closed | -$11.4M |
|
|
82
Annexon
ANNX
$225M
| – | – |
-3,780,694
| Closed | -$19.5M |
|